Preferred Label : finafloxacin;

MeSH note : structure in first source;

MeSH synonym : 3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-1,4-dihydro-4-oxo-;

MeSH CAS label : 3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-1,4-dihydro-4-oxo-;

Is substance : O;

UNII : D26OSN9Q4R;

Details


Main resources

You can consult :


XTORO - Finafloxacin
Summary Basis of Decision (SBD) for Xtoro
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00314
2016
false
false
false
Canada
French
summary of product characteristics
finafloxacin
finafloxacin
Auricular Route of Administration
drug evaluation
risk assessment
Malignant otitis externa caused by Pseudomonas aeruginosa (disorder)
otitis externa
pseudomonas infections
staphylococcal infections
pseudomonas aeruginosa
staphylococcus aureus
anti-bacterial agents
anti-bacterial agents
infant
child
treatment outcome
drug approval
canada
acute disease
fluoroquinolones
fluoroquinolones

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.